148 related articles for article (PubMed ID: 951836)
1. Characterization of a 1100-1300 MW uremic neurotoxin.
Funck-Brentano JL; Man NK; Sausse A; Zingraff J; Boudet J; Becker A; Cueille GF
Trans Am Soc Artif Intern Organs; 1976; 22():163-7. PubMed ID: 951836
[No Abstract] [Full Text] [Related]
2. Middle molecules in uraemia.
Fürst P; Asaba M; Gordon A; Zimmerman L; Bergström J
Proc Eur Dial Transplant Assoc; 1975; 11():417-26. PubMed ID: 1105558
[No Abstract] [Full Text] [Related]
3. Gel-filtration on psoriasic and uremic serum and dialysis fluid.
Lamperi S; Buoncristiani U; Carozzi S; Cozzari M; Icardi A; Trasforini D
Artif Organs; 1981; 4 Suppl():156-9. PubMed ID: 7295083
[TBL] [Abstract][Full Text] [Related]
4. [Uremic toxins. Mechanisms of excretion, diffusibility through membranes and rate of storage].
Nesse AB; Arrizurieta de Muchnik E
Medicina (B Aires); 1984; 44(2):127-36. PubMed ID: 6537453
[No Abstract] [Full Text] [Related]
5. Separation and characterization of uremic metabolites in biologic fluids: a screening approach to the definition of uremic toxins.
Gordon A; Berström J; Fürst P; Zimmerman L
Kidney Int Suppl; 1975 Jan; (2):45-51. PubMed ID: 1057692
[No Abstract] [Full Text] [Related]
6. Technical aspects on middle molecules: separation, isolation, and identification.
Cueille G; Man NK; Sausse A; Farges JP; Funck-Brentano JL
Artif Organs; 1981; 4 Suppl():8-12. PubMed ID: 7295100
[TBL] [Abstract][Full Text] [Related]
7. [Determination of "middle molecules" presenting vitamin B12 molecular size in normal and uremic body fluids (author's transl)].
Cueille G
J Chromatogr; 1978 Jul; 146(1):55-65. PubMed ID: 670358
[TBL] [Abstract][Full Text] [Related]
8. [Uremic toxins. Chromatographic profiles of substances of low and medium molecular weight].
Nesse AB; Arrizurieta de Muchnik E
Medicina (B Aires); 1984; 44(2):117-26. PubMed ID: 6537452
[No Abstract] [Full Text] [Related]
9. What remains of the "middle molecule" hypothesis today?
Brunner H; Mann H
Contrib Nephrol; 1985; 44():14-39. PubMed ID: 3886282
[No Abstract] [Full Text] [Related]
10. An overview of clinical implications of middle molecules and their kinetics in uremia.
Funck-Brentano JL; Man NK
Artif Organs; 1981; 4 Suppl():125-32. PubMed ID: 7295078
[TBL] [Abstract][Full Text] [Related]
11. [Medium molecular weight uremic toxins and endogenous polyamines. Behavior of polymorphonuclear leukocyte chemotaxis with respect to chromatographic peaks of dialysate and standard polyamines].
Stabellini G; Spisani S; Fiocchi O; Stabellini N; Carletti R; Altobelli A; Farinelli A
Boll Soc Ital Biol Sper; 1982 Nov; 58(21):1418-24. PubMed ID: 7159534
[TBL] [Abstract][Full Text] [Related]
12. Nervous system complications in uremia.
Fraser CL; Arieff AI
Ann Intern Med; 1988 Jul; 109(2):143-53. PubMed ID: 2837930
[TBL] [Abstract][Full Text] [Related]
13. Uremic middle molecules exist and are biologically active.
Bergström J; Fürst P; Zimmerman L
Clin Nephrol; 1979 May; 11(5):229-38. PubMed ID: 455821
[No Abstract] [Full Text] [Related]
14. [Sequence analysis of bee venom neurotoxin (apamine) from its tryptic and chymotryptic cleavage products].
Haux P; Sawerthal H; Habermann E
Hoppe Seylers Z Physiol Chem; 1967 Jun; 348(6):737-8. PubMed ID: 5601655
[No Abstract] [Full Text] [Related]
15. Separation, identification of uremic middle molecules, and preliminary study on their toxicity.
Li G; Chu J; Liu X; Yuan Z
Clin Chim Acta; 2004 Dec; 350(1-2):89-98. PubMed ID: 15530464
[TBL] [Abstract][Full Text] [Related]
16. Uremic toxins and the elusive middle molecules.
Schoots A; Mikkers F; Cramers C; de Smet R; Ringoir S
Nephron; 1984; 38(1):1-8. PubMed ID: 6472528
[No Abstract] [Full Text] [Related]
17. [Uremic toxins].
Vanholder R
Nephrologie; 2003; 24(7):373-6. PubMed ID: 14650749
[TBL] [Abstract][Full Text] [Related]
18. [Medium-sized molecules and the process of uremic intoxication].
Lutz W
Pol Tyg Lek; 1976 Jul; 31(27):1173-6. PubMed ID: 951302
[No Abstract] [Full Text] [Related]
19. The fraction b 4-2: isolation, characterization and biological activities with reference to uremic polyneuropathy.
Man NK; Cueille G; Faguer P; Boudet J; Pierrat D; Zingraff J; Sausse A; Funck-Brentano JL
Adv Exp Med Biol; 1987; 223():135-40. PubMed ID: 3447428
[No Abstract] [Full Text] [Related]
20. [Uremic middle-molecule toxins and their removal in hemofiltration].
Kazakov IV; Timokhov VS
Urol Nefrol (Mosk); 1991; (1):67-73. PubMed ID: 1858215
[No Abstract] [Full Text] [Related]
[Next] [New Search]
